InvestorsHub Logo
Followers 40
Posts 7682
Boards Moderated 1
Alias Born 01/04/2006

Re: None

Wednesday, 09/19/2012 11:18:11 AM

Wednesday, September 19, 2012 11:18:11 AM

Post# of 94
Redued doze: $6 ;Cumberland Pharma announces top-line results from a clinical pediatric pain study evaluating the safety and analgesic efficacy of Caldolor (ibuprofen) Injection; Caldolor significantly reduces the number of post-operative narcotic doses (CPIX) 6.02 : Co announced top-line results from a clinical pediatric pain study evaluating the safety and analgesic efficacy of Caldolor Injection in treating pain in tonsillectomy patients ranging from 6 to 16 years old. When administered prior to surgery, Caldolor use was associated with a statistically significant reduction in the number of post-operative narcotic doses required in patients in the efficacy evaluable population. There were also consistent trends toward reduction in pain scores and the incidence of nausea and vomiting in patients receiving Caldolor. Importantly, no safety concerns were observed during this study.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CPIX News